We use cookies to help provide you with the best possible online experience.
By using this site, you agree that we may store and access cookies on your device. Cookie policy.
Cookie settings.
Functional Cookies
Functional Cookies are enabled by default at all times so that we can save your preferences for cookie settings and ensure site works and delivers best experience.
3rd Party Cookies
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Respiratory syncytial virus (RSV)
Respiratory syncytial virus (RSV) is a major respiratory virus that is common over the winter period, typically November to February.
The RSV (Respiratory Syncytial Virus) vaccine is an important preventative measure aimed at protecting those most at risk, particularly adults aged 75 and older, those 65 and over with certain underlying health conditions, and pregnant women.
This vaccine helps reduce the risk of severe respiratory illness by stimulating the immune system to defend against RSV.
We have been inviting these patients via text message and letter and we are staring with the oldest patients first. Due to the volume of patients that we need to invite and the nursing resources available we will be inviting this cohort up until August 2025.
NHS England have been sending out communications reminding patients to book their RSV with their GP surgery, but rest assured we will invite you when it is your ages groups turn and we ask you to only contact the surgery about your RSV when you have received a text or letter from us inviting you to book your appointment.
Published: Feb 27, 2025